Cyfra21-1

Cyfra21-1
Supporting to diagnose Non-Small-Cell Lung Cancer (NSCLC)

Cyfra21-1 belongs to a cytokeratin family, which is normally expressed in epithelial tissues and forms the epithelial cells filament cytoskeleton and it can be used as a circulating tumor marker. Although expressed in all body tissues, its major occurrence is in the lung, particularly in lung cancer tissues, so it is a sensitive, specific, and valuable biomarker for estimation of diagnosis, prognosis, and therapy monitoring of non-small-cell lung cancer (NSCLC), especially of squamous cell subtype.

Diagnosis diseases
Lung Cancer

About Using Reagent

• Sample Types plasma, serum
• Reaction Time 12 mins
• Detection Range 1-500 ng/mL
• Indication Quantitative determination of Cyfra21-1 in human serum/plasma.

Click